相关实验视频
Updated: Jul 27, 2025

11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
55.0K
液体复苏时间在早期败血症复苏时间的影响
Hani I Kuttab1, Chad G Evans1, Joseph D Lykins2
1Department of Emergency Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Journal of intensive care medicine
|June 8, 2023
概括
在败血症中,早期的液体复苏至关重要. 虽然在第一个小时内给出30毫升/千克的晶状体可能会改善生存率,但随着时间的延迟,效益会减少,这表明更早的治疗对败血症的治疗更好.
科学领域:
- 关键护理医学 关键护理医学
- 紧急医疗 紧急医疗
- 复苏科学复苏科学 复苏科学
背景情况:
- 败血症早期液体复苏的最佳时间是患者管理的关键,但仍有争议的方面.
- 严重的败血症和败血性休克需要及时干预,液体给药是初始治疗的基石.
研究的目的:
- 评估液体复苏时间对严重败血症或败血性休克的成年患者的死亡率和临床结果的影响.
- 调查30毫升/公斤晶体剂的施用时间与急诊室环境中的患者存活率之间的关联.
主要方法:
- 一项回顾性队列研究涉及1032名成年患者,他们因严重败血症或败血性休克而在急诊室接受治疗.
- 使用后勤回归分析来评估30毫升/千克晶体剂的时间与死亡率之间的关系,控制各种临床因素.
主要成果:
- 总的死亡率为17.1%. 在前12小时内观察到死亡率增加的趋势,在5小时左右达到顶峰 (OR 1.29).
- 在1小时内服用30毫升/千克的晶类药物与较低的死亡率有关,与在24小时内不达到这一目标相比 (OR2.69).
- 与<1小时相比,在1-3小时之间服用液体增加了延迟低血压 (OR1.83),但没有影响输管,ICU入院或血管压缩剂的使用.
结论:
- 有微弱的证据表明,早些时候 (在1小时内) 对败血症进行液体复苏可能与改善的生存率有关.
- 实现30毫升/千克液体目标的好处似乎随着延迟给药而减少,这凸显了及时干预的重要性.
- 这些发现产生了假设,需要在前性研究中进一步调查,以确认败血症中液体复苏的最佳时间.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29
Cardiopulmonary Resuscitation I: Adult
22
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
22
Acute Respiratory Failure-V
169
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
169

